Successful use of Rectal Pregabalin for the Treatment of Chemotherapy-Induced Neuropathic Pain-a Case Report.
adjuvant analgesic
cancer pain
malabsorption
pregabalin
suppositories
Journal
Journal of palliative care
ISSN: 2369-5293
Titre abrégé: J Palliat Care
Pays: United States
ID NLM: 8610345
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
medline:
11
10
2023
pubmed:
17
7
2023
entrez:
17
7
2023
Statut:
ppublish
Résumé
A 65-year-old female patient could no longer take oral food or medications due to a duodenal occlusion associated with metastatic urothelial carcinoma. Her pre-existing chemotherapy-induced polyneuropathy had been well treated with pregabalin orally. Since only preparations for oral use of pregabalin are available, pregabalin suppositories were compounded by the hospital pharmacy for rectal use in this patient. With the rectal administration, the treatment was successfully continued; we measured a good increase in serum levels and the symptoms improved significantly. Cancer patients often need to be treated with co-analgesics. At the end of life, treatment often cannot be continued due to lack of other than oral administration. Our case adds to the low evidence of pregabalin administered rectally.
Identifiants
pubmed: 37455368
doi: 10.1177/08258597231189151
doi:
Substances chimiques
Pregabalin
55JG375S6M
Analgesics
0
Antineoplastic Agents
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
412-415Déclaration de conflit d'intérêts
Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.